Variant report

Variant	rs12481007
Chromosome Location	chr20:1451572-1451573
allele	A/G
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	RCOR1	chr20:1450181-1452208	IMR90	lung:	n/a	n/a
2	CTCF	chr20:1451480-1451630	AG10803	skin:	n/a	n/a
3	CHD1	chr20:1450304-1451859	IMR90	lung:	n/a	n/a
4	STAT3	chr20:1451531-1451731	MCF10A-Er-Src	breast:	n/a	n/a
5	MXI1	chr20:1450185-1451990	IMR90	lung:	n/a	n/a
6	MAX	chr20:1450426-1451600	A549	lung:	n/a	chr20:1451011-1451021
7	CTCF	chr20:1449985-1451820	A549	lung:	n/a	chr20:1450872-1450885 chr20:1450389-1450402 chr20:1450865-1450886 chr20:1450871-1450887 chr20:1450870-1450888
8	POLR2A	chr20:1451553-1451685	K562	blood:	n/a	n/a

No.	Distal block	Cell Line	Cell type
1	chr20:1447071..1448806-chr20:1450889..1452867,2	MCF-7	breast:
2	chr20:1450041..1452334-chr20:1456617..1458188,2	K562	blood:
3	chr20:1205294..1207984-chr20:1450527..1452708,2	MCF-7	breast:
4	chr20:1397834..1399758-chr20:1450418..1453215,2	K562	blood:

Variant related genes	Relation type
NSFL1C	TF binding region
ENSG00000088833	Chromatin interaction
ENSG00000244588	Chromatin interaction

Extended variants
information (count: 15 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:11)

rs_ID	r²[population]
rs12480584	1.00[AMR][1000 genomes];0.99[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs12481707	1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs17793360	0.93[AMR][1000 genomes];0.95[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs1884393	1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs2273321	1.00[ASN][1000 genomes]
rs3829697	0.89[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs41275406	1.00[ASN][1000 genomes]
rs8118710	0.90[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs8123855	0.89[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs984497	1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs984498	0.82[EUR][1000 genomes];1.00[ASN][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:4 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv522008	chr20:1340390-1638578	Flanking Active TSS Genic enhancers Enhancers Strong transcription Weak transcription Active TSS Bivalent Enhancer ZNF genes & repeats Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	28 gene(s)	inside rSNPs	diseases
2	nsv585206	chr20:1386473-1714362	Strong transcription Enhancers Genic enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Active TSS Transcr. at gene 5' and 3' ZNF genes & repeats Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	28 gene(s)	inside rSNPs	diseases
3	esv1850632	chr20:1393861-1465597	Enhancers Weak transcription Flanking Active TSS Transcr. at gene 5' and 3' Genic enhancers Strong transcription ZNF genes & repeats Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	10 gene(s)	inside rSNPs	diseases
4	nsv833893	chr20:1414615-1527779	Enhancers Strong transcription Bivalent Enhancer Flanking Active TSS ZNF genes & repeats Weak transcription Genic enhancers Flanking Bivalent TSS/Enh Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	11 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:62 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr20:1448200-1451600	Weak transcription	iPS-18 Cell Line	embryonic stem cell
2	chr20:1448200-1451600	Enhancers	Placenta	Placenta
3	chr20:1448200-1451600	Enhancers	Stomach Mucosa	stomach
4	chr20:1448200-1452200	Weak transcription	Primary mononuclear cells fromperipheralblood	Blood
5	chr20:1448200-1455800	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
6	chr20:1448200-1457400	Weak transcription	Spleen	Spleen
7	chr20:1448200-1459000	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
8	chr20:1448400-1452200	Weak transcription	Esophagus	oesophagus
9	chr20:1448800-1452000	Enhancers	Duodenum Mucosa	Duodenum
10	chr20:1448800-1452000	Enhancers	Rectal Mucosa Donor 29	rectum
11	chr20:1449000-1453600	Enhancers	Primary B cells from cord blood	blood
12	chr20:1449000-1454800	Enhancers	Fetal Intestine Small	intestine
13	chr20:1449400-1454000	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
14	chr20:1449400-1454200	Enhancers	K562	blood
15	chr20:1449600-1451800	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
16	chr20:1449600-1451800	Enhancers	HMEC	breast
17	chr20:1449600-1452000	Enhancers	HUVEC	blood vessel
18	chr20:1449600-1452800	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Female	--
19	chr20:1449800-1451600	Enhancers	NHDF-Ad	bronchial
20	chr20:1449800-1452000	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
21	chr20:1449800-1453800	Genic enhancers	Monocytes-CD14+_RO01746	blood
22	chr20:1450000-1451600	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
23	chr20:1450000-1451800	Enhancers	Hela-S3	cervix
24	chr20:1450000-1453000	Genic enhancers	Primary neutrophils fromperipheralblood	blood
25	chr20:1450200-1451800	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
26	chr20:1450200-1452000	Enhancers	NHEK	skin
27	chr20:1450400-1451600	Enhancers	Primary hematopoietic stem cells short term culture	blood
28	chr20:1450400-1453800	Weak transcription	Duodenum Smooth Muscle	Duodenum
29	chr20:1450400-1459000	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
30	chr20:1450400-1459000	Weak transcription	Lung	lung
31	chr20:1450600-1451800	Enhancers	HSMM	muscle
32	chr20:1450600-1452000	Enhancers	Osteobl	bone
33	chr20:1450600-1454600	Weak transcription	Right Ventricle	heart
34	chr20:1450800-1453000	Weak transcription	Fetal Heart	heart
35	chr20:1450800-1454000	Weak transcription	Adipose Nuclei	Adipose
36	chr20:1450800-1456200	Weak transcription	ES-I3 Cell Line	embryonic stem cell
37	chr20:1450800-1458200	Genic enhancers	Primary monocytes fromperipheralblood	blood
38	chr20:1451000-1451600	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
39	chr20:1451000-1452000	Enhancers	Muscle Satellite Cultured Cells	--
40	chr20:1451000-1452000	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
41	chr20:1451000-1452600	Weak transcription	Primary hematopoietic stem cells	blood
42	chr20:1451000-1454000	Weak transcription	Sigmoid Colon	Sigmoid Colon
43	chr20:1451200-1451600	Enhancers	Small Intestine	intestine
44	chr20:1451200-1451600	Enhancers	A549	lung
45	chr20:1451200-1451800	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
46	chr20:1451200-1451800	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
47	chr20:1451200-1452200	Weak transcription	Primary B cells from peripheral blood	blood
48	chr20:1451200-1452800	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
49	chr20:1451200-1453800	Weak transcription	Skeletal Muscle Female	skeletal muscle
50	chr20:1451200-1454800	Enhancers	Fetal Intestine Large	intestine

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links